Pharma’s AI Boom Has Bet on the Wrong Bottleneck
Michael A. Santoro is Professor of Management and Entrepreneurship at the Leavey School of Business, Santa Clara University. He is the author of Wall Street Values: Business Ethics and the Global Financial Crisis (Cambridge University Press) and has written widely on fiduciary duty, financial regulation, and corporate accountability. He is also co-editor of Ethics and the Pharmaceutical Industry (Cambridge University Press). His research focuses on business ethics, financial regulation, and the governance of markets and institutions, including the accountability of artificial intelligence systems. Santoro received a JD from the New York University School of Law and a PhD in Public Policy from Harvard University.
Related Stories
AI News
Bill Gross bets AI can help mass
3 weeks ago
AI News
Nigeria records 93% rise in AI micro
3 weeks ago
AI News
The Italian gelato maker using AI to invent new flavours
3 weeks ago
AI News
Closing the Gap Between Agentic CX Pilots and Production
3 weeks ago
AI News
New Brunswick data centre debate highlights cross
3 weeks ago
AI News
How to Structure an AI Agent Referral Fee Agreement Between Startups
3 weeks ago
AI News
No, AI didn’t delete a Swedish reality TV series
3 weeks ago
AI News
There is no AI in Armageddon. Artificial intelligence is a tool, not an apocalypse
3 weeks ago